PET/CT in Neuroendocrine Tumors / Clinicians' Guides to Radionuclide Hybrid Imaging (PDF)

Valentina Ambrosini is Associate Professor in Nuclear Medicine (sector MED-36, Diagnostic Imaging) at the University of Bologna. Full-time employed Nuclear Medicine Physician at the PET Center, Nuclear Medicine Unit, S.Orsola-Malpighi University Hospital, Bologna, Italy. She received her medical degree and her Ph.D at the University of Bologna. She was trained and became certified specialist in both in Nuclear Medicine and Respiratory Medicine at the University of Bologna. Initially devoted to small animal imaging with PET, her interests were later focused on clinical PET/CT imaging, with both FDG and non-FDG tracers. She performed many novel investigations on PET/CT imaging with FDG and non-FDG tracers, whose results were published in peer reviewed international journals. She teaches Nuclear Medicine at Medical School and in specialty schools of the University of Bologna.

Stefano Fanti is Associate Professor in Nuclear Medicine (sector MED-36, Diagnostic Imaging)  at the University of Bologna. Director of the Nuclear Medicine Unit of the S.Orsola-Malpighi University Hospital, Bologna, Italy. Director of the School of Specialty in Nuclear Medicine of the University of Bologna. He received his medical degree at the University of Bologna. He was trained and became certified specialist in Nuclear Medicine at the University of Bologna. He participated as referent physician to the site planning and start up (2002) of the PET center of the S.Orsola-Malpighi University Hospital that, under his supervision and leadership, is now performing more 10000 exams per year and has become one of the most active in Europe. His interest are focused on PET/CT imaging with both FDG and non-FDG tracers. He has conducted many novel investigations with results published in peer reviewed international journals. He has courses at Medical School (University of Bologna) on Nuclear Medicine, and in specialty schools of the University of Bologna.

“This volume provides a succinct summary of the current status of neuroendocrine malignancy, with a particular focus on PETCT imaging techniques. … The book is likely to be of most interest to clinicians involved in the management of this diverse patient group that includes oncologists, nurses, pathologists, surgeons, radiographers/technologists, radiologists and nuclear medicine physicians. An ideal use is as a quick reference guide both in preparation for and at multidisciplinary meetings.” (Dr. Andy Scarsbrook, RAD Magazine, January, 2017)

“The book is mainly directed to all clinicians interested in the role of nuclear medicine in patients with NETs. Residents and practitioners in nuclear medicine and radiology may also find this book interesting and useful for improving their understanding of the potential of nuclear medicine in patients affected with these tumours and then for explaining this to their referrers.” (Manuela Amato and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, 2017)

“The intended audience includes anyone involved in the multidisciplinary approach to diagnosis and management of patients with neuroendocrine tumors. This includes nuclear medicine physicians, radiologists, technologists, and pathologists, as well as clinical specialists such as oncologists, endocrinologists, and surgeons. … This is a quick read, but it does not fall short in providing a concise, up-to-date overview of the utility of nuclear medicine, particularly PET/CT, for imaging NETs.” (Daniel Thut, Doody's Book Reviews, August, 2016)